V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270019978 | 270007375 | 1.77 | 81.1 | Palliative (P) | 2016-08-20 | 2017-11-14 | Capecitabine | N | N | 270008522 | CAPECITABINE |
| 270019979 | 270007394 | 1.5 | 76.9 | Adjuvant (A) | 2019-12-21 | 2019-12-25 | Capecitabine | 2 | N | 270008636 | CAPECITABINE |
| 270019980 | 270007412 | 1.64 | 82.4 | Adjuvant (A) | 2020-01-07 | 2020-01-07 | Capecitabine + Oxaliplatin 21day | 2 | N | 270008766 | CAPECITABINE + OXALIPLATIN |
| 270019981 | 270007442 | 1.6 | 75.1 | Palliative (P) | 2019-03-26 | 2019-05-04 | Capecitabine + Oxaliplatin 14day | N | N | 270009098 | CAPECITABINE + OXALIPLATIN |
| 270019982 | 270007453 | 1.71 | 63.4 | Curative (C) | 2019-07-04 | 2019-07-31 | Brentuximab | N | N | 270009154 | BRENTUXIMAB |
| 270019983 | 270007457 | null | null | Not known (9) | null | 2018-04-09 | Capecitabine + Oxaliplatin 21day | Y | N | 270009170 | CAPECITABINE + OXALIPLATIN |
| 270019984 | 270007493 | 1.68 | 58.8 | Palliative (P) | 2018-12-19 | 2018-12-19 | CAPECITABINE + OXALIPLATIN | N | N | 270009455 | CAPECITABINE + OXALIPLATIN |
| 270019985 | 270013530 | 1.6 | 97 | Disease modification (D) | 2018-02-18 | 2018-10-17 | Brentuximab | N | N | 270009573 | BRENTUXIMAB |
| 270019986 | 270007534 | 1.77 | 67.3 | Adjuvant (A) | 2017-01-15 | 2017-08-30 | CAPECITABINE + OXALIPLATIN | N | N | 270009706 | CAPECITABINE + OXALIPLATIN |
| 270019987 | 270007576 | 1.65 | 124.4 | Curative (C) | 2017-02-26 | 2017-03-06 | Brentuximab | 02 | N | 270009887 | BRENTUXIMAB |
| 270019988 | 270007606 | 1.76 | 66 | Curative (C) | 2018-04-27 | 2018-04-29 | Capecitabine + Oxaliplatin 21day | 02 | null | 270010050 | CAPECITABINE + OXALIPLATIN |
| 270019989 | 270007671 | null | 78.6 | Palliative (P) | 2017-09-24 | 2020-08-07 | Trial Unspecified | N | N | 270010329 | TRIAL |
| 270019990 | 270007674 | 1.85 | 92.3 | null | 2015-02-28 | 2015-05-02 | BEACOPP-14 | N | N | 270010363 | BEACOPP |
| 270019991 | 270007699 | null | 88.7 | Curative (C) | 2015-11-01 | 2016-02-04 | Trial Unspecified | Y | N | 270010476 | TRIAL |
| 270019992 | 270007747 | 1.73 | 57.6 | Curative (C) | 2015-08-21 | 2015-08-29 | BEACOPP | 01 | null | 270010739 | BEACOPP |
| 270019993 | 270007777 | 0 | 72 | Neo-adjuvant (N) | 2018-02-08 | 2018-04-10 | COPP + Dacarbazine | 02 | N | 270010845 | COPP + DACARBAZINE |
| 270019994 | 270018124 | 0 | 36.3 | Curative (C) | 2016-05-10 | 2016-11-19 | Trial Unspecified | N | N | 270010948 | TRIAL |
| 270019995 | 270007864 | 1.8 | 54.6 | Curative (C) | 2019-02-27 | 2019-04-17 | CETUXIMAB | N | N | 270011143 | CETUXIMAB |
| 270019996 | 270007940 | 1.74 | 78 | Curative (C) | 2018-09-07 | 2018-09-28 | Cetuximab 14 day | null | null | 270011390 | CETUXIMAB |
| 270019997 | 270018149 | 0 | 67 | Adjuvant (A) | null | 2017-09-17 | COPP + Dacarbazine | N | N | 270011446 | COPP + DACARBAZINE |
| 270019998 | 270007983 | 1.56 | 101.7 | Curative (C) | 2017-09-27 | 2017-09-27 | COPP + Dacarbazine | N | Y | 270011521 | COPP + DACARBAZINE |
| 270019999 | 270007989 | 1.62 | null | Curative (C) | 2018-09-24 | 2018-12-17 | BEACOPP-14 | 02 | N | 270011533 | BEACOPP |
| 270020000 | 270008034 | 0 | null | Adjuvant (A) | 2017-11-27 | 2017-12-13 | COPP + Dacarbazine | N | N | 270011646 | COPP + DACARBAZINE |
| 270020001 | 270008062 | null | 71 | Curative (C) | 2019-07-21 | 2019-09-07 | HD EuroNet-PHL-C1 COPDAC | 1 | N | 270011723 | TRIAL |
| 270020002 | 270008132 | 1.25 | 65.85 | Curative (C) | 2018-07-03 | 2018-07-03 | COPP + Dacarbazine | 02 | null | 270011914 | COPP + DACARBAZINE |
| 270020003 | 270008138 | 1.72 | null | Curative (C) | 2016-09-17 | 2016-09-17 | CETUXIMAB | N | N | 270011920 | CETUXIMAB |
| 270020004 | 270013871 | null | 90 | Adjuvant (A) | 2015-02-10 | 2015-05-12 | Trial Unspecified | 01 | null | 270011935 | TRIAL |
| 270020005 | 270008161 | 1.42 | 64.5 | Neo-adjuvant (N) | 2015-06-11 | 2015-08-06 | COPP + Dacarbazine | 2 | null | 270011982 | COPP + DACARBAZINE |
| 270020006 | 270008218 | 1.8 | 59 | null | 2014-07-18 | 2014-10-22 | HD EuroNet-PHL-C1 Relapsed IEP | null | N | 270012187 | TRIAL |
| 270020007 | 270008319 | 1.77 | null | Palliative (P) | 2016-12-11 | 2016-12-25 | Rituximab | 02 | N | 270012463 | RITUXIMAB |
| 270020008 | 270008366 | 1.71 | 108.3 | Palliative (P) | 2014-05-08 | 2014-05-12 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 270012579 | CETUXIMAB + IRINOTECAN + MDG |
| 270020009 | 270008380 | 1.45 | 62.4 | Curative (C) | null | 2017-04-17 | LEAM | N | null | 270012612 | LEAM |
| 270020010 | 270008393 | 1.73 | null | Disease modification (D) | 2017-04-05 | 2018-01-19 | Rituximab | N | N | 270012660 | RITUXIMAB |
| 270020011 | 270008438 | 1.9 | null | Curative (C) | 2014-02-20 | 2014-02-25 | Mini BEAM | N | Y | 270012755 | BEAM |
| 270020012 | 270008585 | 1.71 | 66 | Curative (C) | null | 2015-03-18 | Rituximab (Maintenance) | 2 | N | 270013366 | RITUXIMAB |
| 270020013 | 270016711 | 0.98 | 85.2 | Curative (C) | null | 2016-10-23 | OEPA | 02 | Y | 270013582 | OEPA |
| 270020014 | 270018245 | 1.52 | 71.9 | Palliative (P) | 2017-09-02 | 2018-01-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | 270013992 | CETUXIMAB + IRINOTECAN + MDG |
| 270020015 | 270008724 | 1.7 | null | Curative (C) | 2016-11-14 | 2016-11-16 | BEAM | null | null | 270014196 | BEAM |
| 270020016 | 270008729 | 1.6 | 38 | Curative (C) | 2016-06-13 | 2016-06-18 | ESHAP | N | N | 270014220 | ESHAP |
| 270020017 | 270008744 | 1.66 | 79 | Curative (C) | 2019-09-23 | 2019-09-29 | Cisplatin 100 + RT(H&N) 1 day | N | N | 270014274 | CISPLATIN + RT |
| 270020018 | 270008769 | 1.52 | 29 | Curative (C) | 2018-09-08 | 2018-09-08 | Rituximab | 02 | N | 270014409 | RITUXIMAB |
| 270020019 | 270008825 | 1.58 | 67 | Curative (C) | 2015-12-17 | 2015-12-26 | BEAM | 99 | null | 270014508 | BEAM |
| 270020020 | 270008850 | 1.91 | 90.4 | Curative (C) | 2017-02-13 | 2017-03-01 | OEPA | N | N | 270014558 | OEPA |
| 270020021 | 270008859 | 1.75 | 56.2 | Curative (C) | 2019-01-21 | 2019-01-24 | Rituximab | N | N | 270014564 | RITUXIMAB |
| 270020022 | 270008878 | 1.66 | 92.9 | Curative (C) | 2019-02-13 | 2019-03-06 | ESHAP | N | N | 270014596 | ESHAP |
| 270020023 | 270008892 | 1.87 | 77.7 | Curative (C) | 2015-05-31 | 2015-06-04 | HD EuroNet-PHL-C1 OEPA | N | Y | 270014625 | OEPA |
| 270020025 | 270020199 | 1.78 | 73.5 | Palliative (P) | 2016-05-25 | 2017-03-10 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270014763 | CETUXIMAB + IRINOTECAN + MDG |
| 270020026 | 270019151 | 1.72 | 82 | Curative (C) | 2016-09-03 | 2016-09-15 | LEAM | 2 | N | 270014855 | LEAM |
| 270020027 | 270009027 | null | 75.4 | Curative (C) | 2017-04-02 | 2017-04-02 | Rituximab | N | N | 270014886 | RITUXIMAB |
| 270020028 | 270009053 | null | 51.4 | Curative (C) | 2016-06-24 | 2016-06-28 | Mini BEAM | 02 | N | 270014941 | BEAM |